Viewing Study NCT00050102


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-02-24 @ 3:15 PM
Study NCT ID: NCT00050102
Status: COMPLETED
Last Update Posted: 2011-01-28
First Post: 2002-11-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module